Continuous Glucose Monitoring Following Hospital Discharge

Part of paid clinical trials in Columbus, Ohio.

Sponsor: Kathleen Dungan
Study ID: NCT05360056
Status: Active Not Recruiting

Conditions

Type 2 Diabetes

Eligibility Criteria

Sex: ALL
Age: 18 Years - N/A
Healthy Volunteers: Not accepted

Interventions

DexCom G6 — DEVICE
Wearable continuous glucose monitor

Study Details

In this 12-week prospective observational cohort study, hospitalized insulin-requiring patients with T2D will receive a Dexcom continuous glucose monitor (CGM) to wear post-hospital discharge. Patients will complete surveys assessing patient-reported outcomes prior to CGM use and following completion of the study. CGM data will be captured by the patient smartphone app and analyzed. Patients will receive personalized CGM targets and alerts for hyperglycemia and hypoglycemia. Customized reports/ decision support will be sent to the usual diabetes provider. The initial observational cohort study design will be followed by an extension phase of 12 weeks in which data on continuation of use and glucose control will be collected but no further reports will be communicated to providers.